We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Recurrent focal segmental glomerulosclerosis after kidney transplantation.
- Authors
Trachtman, Rebecca; Sran, Simranjeet; Trachtman, Howard
- Abstract
Focal segmental glomerulosclerosis (FSGS) is an important cause of glomerular disease in children and adolescents and nearly 50 % of affected patients will progress to end-stage kidney disease over a 5 to 10-year period. Unfortunately, there is no established treatment for disease in the native kidney. Moreover, up to 55 % of patients develop recurrent disease after receiving a kidney transplant, with a substantially higher risk in patients who have already experienced recurrent disease in a prior transplant. A number of clinical and laboratory factors have been identified as risk factors for this complication. In addition, new investigations into podocyte biology and circulating permeability factors have shed light on the cause of recurrent the disease. While a number of novel therapeutic agents have been applied in the management of this problem, there still is no proven treatment. In this review, we summarize recent advances in the epidemiology, pathophysiology, and treatment of recurrent FSGS in pediatric patients who have received a kidney transplant.
- Subjects
TREATMENT of glomerulonephritis; SURGICAL complication risk factors; RITUXIMAB; GENETICS; GLOMERULONEPHRITIS; KIDNEY transplantation; PLASMAPHERESIS; DISEASE relapse; DISEASE risk factors
- Publication
Pediatric Nephrology, 2015, Vol 30, Issue 10, p1793
- ISSN
0931-041X
- Publication type
Article
- DOI
10.1007/s00467-015-3062-1